Recent studies suggest that carbon monoxide (CO), which is produced in significant quantities in many brain regions including the hypothalamus, may function as a neurotransmitter.
lntroductlon
Carbon monoxide (CO) is a gas which recently has been demonstrated to be produced in large quantities by the brain (l-4, for review).
The enzyme hems oxygenase is responsible for the production of CO in the brain using heme as a substrate (2) (3) (4) (5) . Along with CO, biliverdin is also produced from the heme oxygenase cleavage of heme (2-5). To date, two isoforms of heme oxygenase have been isolatedheme oxygenaand heme oxygenase-2 (3,6,7). Heme oxygenamRNA and protein are generally in very low to undetectable concentrations in the brain until induced by specific stimuli such as heat shock or glutathione depletion (2,3). Heme oxygena-2, on the other hand, is widely expressed in the brain and is responsible for the impressive CO-generating abil'ky of the brain (37). Why the brain produces so much CO is unclear, especially since it does not have a significant rde in the degradation of hemoglobin like the other major CO-producing tissue in the body, the spleen (4).
One possibility, which has received considerable attention in the last few years, is that CO functions as a neurotransmitter in the brain much in the same way as proposed for nitric oxide (1, for review). Along these lines, CO has been proposed to function in pyramidal cells of the hippocampus as a retrograde messenger for long term potentiation (69). CO has also been recently suggested to function as a transmitter in olfactory neurons (7) and in chemosensor neurons in the carotid body (10).
Of significant interest, a robust CO production has also been reported in the hypothalamus of the rat (3). However, the precise significance of this finding remains unclear. In order to provide further insight into the possible role of CO in the hypothalamus, the present study investigated whether CO is capable of modulating gonadotropin releasing hormone (GnRH) secretion fromthe medial basal hypothalamus of the rat incubated in vitro.
--*To whom correspondence should be addressed. On the day of the experiment (day 71), the animals were sacriiiced at 09OOh by decapitation, and the medial basal hypothalamus (MBH) was rapidly dissected as described prevfousty by our laboratory (11). Individual MBH fragments were immediately placed in individual wells of a 24 plate culture dish in icecold Krebs-Ringer Bicarbonate buffer (KRB; pH=7.4; Sigma Chemical Co. St. Louis, MO), containing bacitracin (2OtM; Sigma Chemical Co.). The media was replaced with fresh KRB buffer and the MBH fragments were preincubated for 1 hour in a Dubnoff metallic shaking incubator under a 95% O,-5% CO, atmosphere at 37°C for stabilization of GnRH release levels. After the 1 hour preincubation period, the media was removed and replaced with medii containing vehicle or the various test compounds for a 30 minute incubation period. At the end of the 30 minute incubation period, the media was collected for subsequent radioimmunoassay for GnRH as described below and the viability of the fragments was tested by incubation with 56 mM KCL All fragments in each of the respective groups responded with a marked elevation of GnRH release to KCL stimulation, verifying that the tissues were viable. The drugs used in these studies were hematin, (Aldrich Chemical Co., Milwaukee, WI) a substrate molecule for CO production (2,12,13), zinc protoporphyrin IX (Research Biochemical International, Natick, MA) a heme oxygenase inhibitor (2,13,14), and hemoglobin (Calbiochem, La Jolla, CA) a CO-scavenger molecule (t,2,15).
GnRH Radklmmunoassay:
The radioimmunoassay of GnRH was performed as described previously by our laboratory (11). The first antibody was generously provided by Dr. M. Kelly (Oregon Primate Research Center) and used at a final dilution of 1:625,000 with a sensitivity of 0.2pgAube. Hormone levels were expressed as pg/well/30 minutes. The intra and interassay variabilities were 10.2% and 17.6% respectively.
Statlstkal
Analysis: Each group consisted of 4-6 animals per group. The results were expressed as means+ standard error. Significance of difference was assessed by one-way ANOVAfollowed by comparisons between treatment means using the Student-NewmanKeuls multirange test Pvalues co.05 were considered significant.
Results
In the initial experiment, the effect of hematin on GnRH release from MBH fragments was examined using a 1OpM and 1OOpM dose. As shown in Figure 1 , the 10pM dose had no significant effect on GnRH release, however the 1OOtM dose of hematin induced a large release of GnRH (PcO.05). In a subsequent experiment, it was found that an intem?ediate (5OpM) dose of hematin effectively stimulated GnRH release (Figure 2) . Therefore, the 5OpM dose of hematin was used in all subsequent experiments. As also shown In Figure 2 , the stimulatory effect of the 5OpM dose of hematin appeared to require heme oxygenase activity as it was blocked by co-incubation with the heme oxygenase inhibitor, zinc protoporphyrin IX. Zinc protoporphyrin IX alone also appeared to lower basal GnRH levels as compared to the control, but this effect was not statistically significant. The effect of hematin on GnRH release appeared to be due to the heme oxygenasegenerated product, CO, as evidenced by the fact that the effect of hematin on GnRH release was blocked by coincubatkm with the CO-scavenger molecule, hemoglobin (Figure 3) . Biliverdin, the other heme oxygenasegenerated product, did not stimulate GnRH release from MBH fragments, and in fact was inhibiiory to GnRH release (Figure 4) .
The present studies demonstrate that hematin, a substrate for CO production, markedly stimulates GnRH release from MBH fragments incubated in vitro. The effect of hematfn required heme oxygenase, as the heme oxygenase inhibitor, ZnPP blocked the ability of hematin to induce GnRH release.
Since heme oxygena~catalyzed cleavage of hematin yields two products (CO and biliverdin), either product could mediate the effect d hematin on GnRH release. The findings of the present study suggests that CO is the heme oxygenase-generated product which mediates hematin's effect on GnRH release. Evidence supporting this contention was derived from studies demonstrating that the CO-scavenger molecule, hemoglobin, completely reversed the effect of hem&in when coincubated with hematin. Likewise, the other "1 T product of the HO reaction, biliverdin, did not stimulate GnRH release but was in fact inhibitory. The inhibition of GnRH release observed for biliverdin may be due to ks previous reported ability to inhibit brain heme oxygenase activity via end-product inhibition (16). The effect of hematin to stimulate GnRH release appears to be specific and not a general phenomenon, as hematin has been reported to inhibit stimulated corticotropin releasing factor secretion (17). The mechanism whereby CO modulates GnRH release is unclear. Like nitric oxide, CO may exert its effects via its ability to bind to the heme moiety in hemoproteins such as guanylate cyclase or cyclooxygenase, inducing a conformation change leading to activation of the enzymes (1 and 3, for review). In support of this possibility, CO has been shown to potently regulate cGMP levels in olfactory neurons (4).
Whether CO exerts its effect directly on GnRH neurons or indirectly through intemeurons is also unclear.
Preliminary studies from our laboratory suggest that the effect d CO may be exerted directly on GnRH neurons, since hematin was found to also potently stimulate GnRH release from immortalized GnRH (GTl-7) neurons cultured in vitro (Lamar CL, Mahesh VB and Brann DW, unpublished observations).
While further work is necessary to characterize the precise site and mechanism of action of CO in the regulation of GnRH secretion, the present studies demonstrate for the first time that heme molecules can stimulate GnRH release from the MBH of the steroidprimed ovatiectomized adult rat. This effect appears to be mediated by CO which is produced by heme oxygenasecatalyzed cleavage of hematin. The present findings, combined with the previous studies demonstrating that the hypothalamus possesses significant quantities of heme oxygenase2 (2) and has a robust CO production rate (3) suggests that CO may function as a transmitter in the hypothalamus involved in regulating the neurosecretory activity of GnRH neurons.
